European Parliament ready to vote on MDD (medical device directive) review in December
This article was originally published in Clinica
Executive Summary
The European Parliament is now due to vote in plenary on the text of the proposed review of the medical device directives during the second week of December. This follows the adoption of the report on the review by its environment, public health and food safety committee on October 4. This is the first reading by the Parliament. The text is also being studied by the Council of Ministers.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.